Inventor · disambiguated record
Edgar Jacoby
Also filed as: JACOBY EDGAR
13 granted patents·10 pending applications·21 citations·filing 2005–2023
84Inventor score
Files withJANSSEN PHARMACEUTICA NV8JANSSEN SCIENCES IRELAND UNLIMITED CO7BREITENSTEIN WERNER2NOVARTIS AG2BERGHAUSEN JOERG1
Top patents by PatentIndex Score
23 records- 0185US8440693B2Substituted isoquinolinones and quinazolinonesBERGHAUSEN JOERG·Filed 2010·Granted May 14, 2013·14 cites·15 claims
- 0278US8163773B2Organic compoundsBREITENSTEIN WERNER·Filed 2006·Granted Apr 24, 2012·6 cites·15 claims
- 0367US9051279B2Substituted isoquinolinones and quinazolinonesNOVARTIS AG·Filed 2013·Granted Jun 9, 2015·1 cites·14 claims
- 0461US2025011326A1Fused heterocyclic derivatives and their use in the treatment of hbv infectionJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
- 0559US11186589B2Cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 30, 2021·0 cites·20 claims
- 0657US2024279227A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2022·Application pending·0 cites
- 0757US2024287070A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2022·Application pending·0 cites
- 0853US2019119299A1Cyanoindoline derivatives as nik inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 0950US2023091047A1Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 1050US2006211747A1Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this methodFURET PASCAL·Filed 2005·Application pending·0 cites
- 1149US2022259186A1Heterocyclic immunomodulators as pdl1 checkpoint inhibitorJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 1248US11236084B2Substituted azaindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Feb 1, 2022·0 cites·15 claims
- 1347US11491148B2Amide derivatives useful in the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Nov 8, 2022·0 cites·19 claims
- 1447US2022089568A1Dihydroorotate dehydrogenase inhibitorsJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1544US11096931B2Amide derivatives useful in the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Aug 24, 2021·0 cites·16 claims
- 1644US2017266189A1Pyrimido[4,5-b]quinoline-4,5(3H,10H)-dionesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1743US9649314B2Pyrimido[4,5-b]quinoline-4,5(3H,10H)-dionesJACOBY EDGAR·Filed 2013·Granted May 16, 2017·0 cites·2 claims
- 1841US11053248B2[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 6, 2021·0 cites·9 claims
- 1941US2010087427A1Pyrrolidine derivatives for the treatment of a disease depending on the activity of reninBREITENSTEIN WERNER·Filed 2005·Application pending·0 cites
- 2039US11180487B2Substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 23, 2021·0 cites·15 claims
- 2139US11136311B2Heteroaromatic derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 5, 2021·0 cites·15 claims
- 2239US11001569B26-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 11, 2021·0 cites·8 claims
- 2336US10947242B2[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 16, 2021·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Edgar Jacoby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →